Medical Adhesives Market Trends

Medical Adhesives Market size was valued at USD 9.41 Billion in 2023 and is poised to grow from USD 10.07 Billion in 2024 to USD 15.85 Billion by 2032, growing at a CAGR of 7% during the forecast period (2025-2032).

Global medical adhesives market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'H.B. Fuller ', 'Johnson & Johnson ', 'Ashland Inc. ', '3M Company ', 'Arkema Group ', 'Henkel AG & Company ', 'Chemence ', 'Avery Dennison Corporation ', 'Dow Inc. ', 'Cohera Medical, Inc. ', 'Ethicon Inc. ', 'Baxter International ', 'Nitto Denko Corporation ', 'Braun Melsungen AG ', 'Scapa Group Plc ', 'Adhezion Biomedical LLC ', 'Coviden (Mediatronic PLC) ', 'Dentsply Sirona ', 'Permabond LLC ', 'Masterbond Inc.'

As a result of an unhealthy lifestyle, the occurrence of cardiovascular disease is rising worldwide. Cardiovascular disease is the leading cause of death worldwide, according to the World Health Organization (WHO). The most common types of cardiovascular illness are congenital heart disease, stroke, peripheral artery disease, arrhythmia, congestive heart failure, cardiac arrest, hypertension, and coronary artery disease. Medical adhesives, such as bandages, surgical tapes, wound care patches, and transdermal patches, are widely used in the healthcare industry. To reduce bleeding, medical adhesives such as cyanoacrylate and fibrin are commonly used in cardiovascular surgery.

Medical adhesives, such as bandages, surgical tapes, wound care patches, and transdermal patches, are widely used in the healthcare market. In cardiovascular surgery, medical adhesives such as cyanoacrylate and fibrin are used extensively to control haemorrhage because of their ability to provide effective hemostasis in a range of aortic and cardiac surgeries.

Asia Pacific is projected to be the fastest growing regional market over the forecast period. The Asia Pacific region’s large population accelerated healthcare awareness, and increased risk of wound infections are the primary growth drivers. The region's large number of diabetic patients is also expected to help the medical adhesives market grow. The United Nations estimates that Asia Pacific is home to 60% of the world's population. Furthermore, Asia Pacific has a large number of diabetics. According to the Asia Pacific Diabetes Prevention Organization, Asia Pacific accounts for approximately 60% of all type 1 diabetes cases worldwide. This increases the demand for medical adhesive products such as transdermal insulin patches and other similar products in the region.